![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The Pharmacokinetics and Safety of the Direct Acting Antiviral Regimen of ABT-450/r, Ombitasvir with/without Dasabuvir in Subjects with Mild, Moderate and Severe Renal Impairment Compared to Subjects with Normal Renal Function
|
|
|
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Amit Khatri, Sandeep Dutta, Thomas Marbury, Richard A Preston, Lino Rodrigues, Haoyu Wang, Walid Awni, Rajeev Menon
![AASLD1.gif](../images/111414/111414-6/AASLD1.gif)
![AASLD2.gif](../images/111414/111414-6/AASLD2.gif)
![AASLD3.gif](../images/111414/111414-6/AASLD3.gif)
![AASLD4.gif](../images/111414/111414-6/AASLD4.gif)
![AASLD5.gif](../images/111414/111414-6/AASLD5.gif)
![AASLD6.gif](../images/111414/111414-6/AASLD6.gif)
![AASLD7.gif](../images/111414/111414-6/AASLD7.gif)
![AASLD8.gif](../images/111414/111414-6/AASLD8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|